DE3854300D1 - Lymphocyteninhibierung durch hla-peptide. - Google Patents

Lymphocyteninhibierung durch hla-peptide.

Info

Publication number
DE3854300D1
DE3854300D1 DE3854300T DE3854300T DE3854300D1 DE 3854300 D1 DE3854300 D1 DE 3854300D1 DE 3854300 T DE3854300 T DE 3854300T DE 3854300 T DE3854300 T DE 3854300T DE 3854300 D1 DE3854300 D1 DE 3854300D1
Authority
DE
Germany
Prior art keywords
ctl
peptides
hla peptides
alpha
lymphocyte inhibition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3854300T
Other languages
English (en)
Other versions
DE3854300T2 (de
Inventor
Alan Krensky
Peter Parham
Carol Clayberger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Original Assignee
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leland Stanford Junior University filed Critical Leland Stanford Junior University
Application granted granted Critical
Publication of DE3854300D1 publication Critical patent/DE3854300D1/de
Publication of DE3854300T2 publication Critical patent/DE3854300T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE3854300T 1987-01-30 1988-01-27 Lymphocyteninhibierung durch hla-peptide. Expired - Fee Related DE3854300T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US884687A 1987-01-30 1987-01-30
US13854787A 1987-12-24 1987-12-24
PCT/US1988/000245 WO1988005784A1 (en) 1987-01-30 1988-01-27 Lymphocyte inhibition by hla peptides

Publications (2)

Publication Number Publication Date
DE3854300D1 true DE3854300D1 (de) 1995-09-14
DE3854300T2 DE3854300T2 (de) 1996-01-11

Family

ID=26678694

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3854300T Expired - Fee Related DE3854300T2 (de) 1987-01-30 1988-01-27 Lymphocyteninhibierung durch hla-peptide.

Country Status (7)

Country Link
EP (1) EP0365525B1 (de)
AT (1) ATE126237T1 (de)
AU (1) AU619458B2 (de)
CA (1) CA1339185C (de)
DE (1) DE3854300T2 (de)
DK (1) DK549188A (de)
WO (1) WO1988005784A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723128A (en) * 1987-01-30 1998-03-03 The Board Of Trustees Of The Leland Stanford Junior University Cytotoxic T-cell lymphocyte ("CTL") activity regulation by class I MHC peptides
US7011834B1 (en) 1987-01-30 2006-03-14 The Board Of Trustees Of Leland Stanford Junior University Immunomodulating dimers
US5888512A (en) * 1987-01-30 1999-03-30 Board Of Trustees Of The Leland Stanford Junior University Lymphocyte activity regulation by HLA peptides
JP3015058B2 (ja) * 1989-03-03 2000-02-28 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 表面レセプター活性のクラスｉｍｈｃ調節
DE4143467C2 (de) * 1991-05-17 1995-02-09 Max Planck Gesellschaft Peptidmotiv und dessen Verwendung
CA2122266A1 (en) * 1991-11-08 1993-05-13 Carol Clayberger Cd8 binding domain peptides
ZA932568B (en) * 1992-04-24 1993-11-12 Baylor College Midecine A Non Production of recombinant human lactoferrin
DE69332485T2 (de) * 1992-08-11 2003-11-13 The President And Fellows Of Harvard College, Cambridge Immunmodulierende peptide
DE4238416A1 (de) * 1992-11-13 1994-05-19 Max Planck Gesellschaft Bestimmung von Peptidmotiven auf MHC-Molekülen
AU6034894A (en) * 1993-02-17 1994-09-14 Immune Network Research Ltd Methods for modifying the t cell repertoire of the immune system
US6162434A (en) * 1995-05-03 2000-12-19 Sangstat Medical Corporation Cytomodulating peptide for inhibiting lymphocyte activity
US5753625A (en) * 1995-05-12 1998-05-19 Sangstat Medical Corporation Treatment for inhibiting the progression of autoimmune disease
AU7010996A (en) * 1995-08-30 1997-03-19 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Selective elimination of t cells that recognize specific preselected targets
US6436903B1 (en) 1996-05-22 2002-08-20 Stanford University (Board Of Trustees Of The Leland Standford Junior University) Immunomodulating compounds comprising d-isomers of amino acids
WO1997044351A1 (en) * 1996-05-24 1997-11-27 The Board Of Trustees Of Leland Stanford Junior University Immunomodulating dimers
US6696545B1 (en) 1997-04-11 2004-02-24 Sangstat Medical Corporation Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
CA2286478A1 (en) 1997-04-11 1998-10-22 Sangstat Medical Corporation Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
US7094413B2 (en) 2002-01-24 2006-08-22 Sangstat Medical Corporation Combined therapy for treatment of HIV infection
EP1768662A2 (de) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Immunstimulatoren kleiner moleküle und assays für deren nachweis

Also Published As

Publication number Publication date
AU1342388A (en) 1988-08-24
DK549188D0 (da) 1988-09-30
EP0365525A1 (de) 1990-05-02
EP0365525A4 (en) 1990-12-12
AU619458B2 (en) 1992-01-30
CA1339185C (en) 1997-07-29
ATE126237T1 (de) 1995-08-15
DE3854300T2 (de) 1996-01-11
WO1988005784A1 (en) 1988-08-11
EP0365525B1 (de) 1995-08-09
DK549188A (da) 1988-11-30

Similar Documents

Publication Publication Date Title
DE3854300D1 (de) Lymphocyteninhibierung durch hla-peptide.
ES2128362T3 (es) Fragmentos de proteinas de prion.
ATE183514T1 (de) Peptide des menschlichen proteins p53 zum gebrauch in menschlichen-zytotoxischen-t-zell- antwort-induzierenden kompositionen sowie menschliche p53-protein-spezifische t-lymphocyten
GR3034964T3 (en) Lymphocyte activity regulation by hla peptides.
IL94039A0 (en) Antibodies to anti-cytotoxic proteins
ZA975851B (en) Hepatocyte grown factor receptor agonists and uses thereof
DE68926675D1 (de) Von mhc gestützte konjugate zur verwendung bei der steigerung der autoimmunität
AU4128089A (en) Monoclonal antibodies specific to human epidermal growth factor receptor and therapeutic methods employing same
ES2120964T3 (es) Peptidos osteogenicos.
ATE250625T1 (de) IM WESENTLICHEN REINES ZONULIN ALS PHYSIOLOGISCHER MODULATOR VON ßTIGHT JUNCTIONSß BEI SÄUGERN
DK1129186T3 (da) Et faktor VIII-polypeptid med faktor VIII:C-aktivitet
IL134982A0 (en) Antibodies which react with polypeptides of cd-44 surface proteins and diagnostic and pharmaceutical compositions prepared therewith
DE69434384D1 (de) Metalkomplexbildner
AU5214893A (en) Antibodies specific to extracellular segments of human and immunoglobulin anchoring peptides
ES2186717T3 (es) Regulacion de la actividad de los linfocitos t citotoxicos ("ctl") mediante peptidos de la clase i del mhc.
ATE63126T1 (de) Tetra- und penta-peptide mit der sequenz lysylarginyl-aspartyl, und ihre verwendung als antithrombotika.
DE69330352D1 (de) Mittel und methoden zur verbesserung der keratinocytenadhäsion an der haut
ATE225806T1 (de) D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet
DK0625157T3 (da) Blodplade-GPIIIaP1A1- og -P1A2-epitoper og fremstilling og anvendelse deraf
ATE139259T1 (de) Selbstantigen der primären lebercirrhose
DK0463053T3 (da) Fremstilling og anvendelse af anthelmintiske midler og beskyttende immunogener
SE8604991D0 (sv) Snake venom growth arresting peptide
ES2061566T3 (es) Anticuerpos monoclonales contra la proteina e7 del papilomavirus humano tipo 16, procedimiento para su preparacion, asi como su empleo.
ITRM920506A1 (it) Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi.
DK0597043T3 (da) Porcine adipocytantigener og deres anvendelse til immunologisk bekæmpelse af fedt

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee